Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Cancer in United States

7251 results

Sort By:

Delayed or Upfront Brain RAdiotherapy in Treatment naïve Lung Cancer Patients With Asymptomatic or Minimally Symptomatic Brain Metastases and ALK rEarrangements

Study ID: NCT05987644
Start Date: 2024-03-07
End Date: 2027-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

56

Intervention / Treatment

Alectinib

Stereotactic Radiosurgery

Sponsor

Joshua Palmer

Source: clinicaltrials.gov

Share:
Add to list

A Longitudinal Observational Study of the Natural History and Management of Patients With HCC

Study ID: NCT02954094
Start Date: 2016-12
End Date: 2025-10
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

10000

Intervention / Treatment
Sponsor

Target PharmaSolutions, Inc.

Source: clinicaltrials.gov

Share:
Add to list

A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)

Study ID: NCT06952504
Start Date: 2025-05-22
End Date: 2032-05-24
Study Type

Interventional

Study Phase

Phase3

No. of Participants

1123

Intervention / Treatment

Pembrolizumab

Carboplatin

Paclitaxel

Docetaxel

Sacituzumab Tirumotecan

Sponsor

Merck Sharp & Dohme LLC

Source: clinicaltrials.gov

Share:
Add to list

Pediatric Classical Hodgkin Lymphoma Consortium Study: cHOD17

Study ID: NCT03755804
Start Date: 2018-12-12
End Date: 2028-07-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

250

Intervention / Treatment

bendemustine

Etoposide

Doxorubicin

Bleomycin

Vincristine

Vinblastine

Prednisone

Filgrastim

Bentuximab Vidotin

Cyclophosphamide

DTIC

Quality of Life Measurements

Radiotherapy

Sponsor

St. Jude Children's Research Hospital

Source: clinicaltrials.gov

Share:
Add to list

Rural Colon Cancer Screening Toolkit Intervention

Study ID: NCT04651504
Start Date: 2020-12-02
End Date: 2026-07-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

83663

Intervention / Treatment

Colorectal Cancer Toolkit

Sponsor

Washington University School of Medicine

Source: clinicaltrials.gov

Share:
Add to list

Beamion LUNG-1: A Study to Test Different Doses of Zongertinib in People With Different Types of Advanced Cancer (Solid Tumours With Changes in the HER2 Gene)

Study ID: NCT04886804
Start Date: 2021-07-02
End Date: 2028-08-30
Study Type

Interventional

Study Phase

Phase1

No. of Participants

554

Intervention / Treatment

zongertinib

Sponsor

Boehringer Ingelheim

Source: clinicaltrials.gov

Share:
Add to list

Improving Survival for Metastatic Lobular Breast Cancer (PLUMB Registry)

Study ID: NCT05964504
Start Date: 2023-12-20
End Date: 2034-02-28
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

12

Intervention / Treatment

Blood Specimen

Sponsor

University of California, San Francisco

Source: clinicaltrials.gov

Share:
Add to list

TCF-001 TRACK (Target Rare Cancer Knowledge) Study

Study ID: NCT04504604
Start Date: 2020-10-01
End Date: 2025-12
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

400

Intervention / Treatment

FoundationOne CDx and FoundationOne Liquid CDx

Sponsor

TargetCancer Foundation

Source: clinicaltrials.gov

Share:
Add to list

Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant

Study ID: NCT05103904
Start Date: 2022-04-19
End Date: 2026-11-04
Study Type

Interventional

Study Phase

Phase2

No. of Participants

19

Intervention / Treatment

Laboratory Biomarker Analysis

Lenvew

Sponsor

Emory University

Source: clinicaltrials.gov

Share:
Add to list

XL092 in Patients With Metastatic Castration-Resistant Prostate Cancer

Study ID: NCT06568562
Start Date: 2024-12-09
End Date: 2028-12
Study Type

Interventional

Study Phase

Phase2

No. of Participants

32

Intervention / Treatment

XL092

Sponsor

University of Utah

Source: clinicaltrials.gov

Share:
Add to list